Close
Nordic 9Nordic 9

BVF Partners (investor - Others)

United States bvflp.com
See something wrong or missing? Let us know
Offices:New York

BVF Partners is an American hedge fund that invests in small-cap biotechnology companies.

Average round investment:120M USD
Average number per year:1.0
Distribution: 2024 (1)
Portfolio companies: United Kingdom Pheon Therapeutics
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to BVF Partners

Name Criteria
United States Alpha Wave Global
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States TCGX
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom AstraZeneca
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Patient Square Capital
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Perceptive Advisors
81%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Catalio Capital Management
80%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Iconiq Capital
80%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States Rock Springs Capital
79%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Canada Omers Ventures
79%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 5.5
  • Active last 12 months: Yes
United States Viking Global Investors
78%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.4
Top